Generic placeholder image

Current Gene Therapy

Editor-in-Chief

ISSN (Print): 1566-5232
ISSN (Online): 1875-5631

Getting to the Heart of the Matter: Exploring Opportunities for Gene Therapy Treatment of Dystrophic Cardiomyopathy

Author(s): Steven M. Kolodziejczyk and Lynn A. Megeney

Volume 4, Issue 2, 2004

Page: [195 - 198] Pages: 4

DOI: 10.2174/1566523043346516

Price: $65

Abstract

Muscular dystrophies are broadly classed as skeletal muscle disease entities of genetic origin. Accordingly, the development and application of gene therapy treatment modalities has focused on skeletal muscle gene replacement. Irrespective of this generalization, most forms of dystrophy are accompanied by progressive cardiomyopathy and cardiac involvement in muscular dystrophies is now recognized as an independent risk for patient morbidity. In this review, we summarize the available murine strains most suitable for modeling the dystrophic myocardium and discuss the use of adenoviral based vector systems as the preferred gene delivery vehicle for modulating dystrophic cardiomyopathy.

Keywords: dystrophy, dystrophic cardiomyopathy, heart, adenovirus, coxsackie virus


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy